🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 04 Jul 2026 · HPRA open data

Amgen Europe B.V., — Licensed Medicines

62 medicines held by Amgen Europe B.V., on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 62 products held by Amgen Europe B.V.,
MedicineActive substanceLicence holderStatus
Otezla 30 mg film-coated tablets
EU/1/14/981/002-003
 Apremilast Amgen Europe B.V., —
Parsabiv 10 mg solution for injection
EU/1/16/1142/009-012
 Etelcalcetide hydrochloride Amgen Europe B.V., —
Parsabiv 2.5 mg solution for injection
EU/1/16/1142/001-004
 Etelcalcetide hydrochloride Amgen Europe B.V., —
Parsabiv 5 mg solution for injection
EU/1/16/1142/005-008
 Etelcalcetide hydrochloride Amgen Europe B.V., —
Prolia 60 mg solution for injection in pre-filled syringe
EU/1/10/618/1-4
 Denosumab Amgen Europe B.V., —
Repatha 140 mg solution for injection in pre-filled pen
EU/1/15/1016/002-005
 Evolocumab Amgen Europe B.V. —
Repatha 140 mg solution for injection in pre-filled syringe
EU/1/15/1016/001
 Evolocumab Amgen Europe B.V., —
Repatha 420 mg solution for injection in cartridge
EU/1/15/1016/006-007
 Evolocumab Amgen Europe B.V. —
TEPEZZA 500 mg powder for concentrate for solution for infusion
EU/1/25/1941/001
 Teprotumumab Amgen Europe B.V., —
Uplizna 100 mg concentrate for solution for infusion
EU/1/21/1602/001
 Inebilizumab Amgen Europe B.V., —
Vectibix 20 mg/mL concentrate for solution for infusion
EU/1/07/423/001-003
 Panitumumab Amgen Europe B.V., —
XGEVA 120 mg solution for injection
EU/1/11/703/001-002
 Denosumab Amgen Europe B.V., —
← 1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.